Concourse Financial Group Securities’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,280
| Closed | -$2.09K | – | 3686 |
|
|
2024
Q4 | $2.09K | Hold |
1,280
| – | – | ﹤0.01% | 2010 |
|
|
2024
Q3 | $2.55K | Sell |
1,280
-300
| -19% | -$597 | ﹤0.01% | 1962 |
|
|
2024
Q2 | $5.53K | Hold |
1,580
| – | – | ﹤0.01% | 1844 |
|
|
2024
Q1 | $4.38K | Hold |
1,580
| – | – | ﹤0.01% | 1910 |
|
|
2023
Q4 | $2.69K | Hold |
1,580
| – | – | ﹤0.01% | 1970 |
|
|
2023
Q3 | $1.63K | Sell |
1,580
-25
| -2% | -$26 | ﹤0.01% | 2028 |
|
|
2023
Q2 | $1.86K | Hold |
1,605
| – | – | ﹤0.01% | 2028 |
|
|
2023
Q1 | $2.42K | Sell |
1,605
-1,916
| -54% | -$2.89K | ﹤0.01% | 2020 |
|
|
2022
Q4 | $8.8K | Buy |
3,521
+554
| +19% | +$1.39K | ﹤0.01% | 1696 |
|
|
2022
Q3 | $13K | Buy |
2,967
+2,549
| +610% | +$11.2K | ﹤0.01% | 1415 |
|
|
2022
Q2 | $1K | Sell |
418
-913
| -69% | -$2.18K | ﹤0.01% | 2103 |
|
|
2022
Q1 | $8K | Hold |
1,331
| – | – | ﹤0.01% | 1747 |
|
|
2021
Q4 | $12K | Buy |
1,331
+259
| +24% | +$2.34K | ﹤0.01% | 1802 |
|
|
2021
Q3 | $11K | Buy |
1,072
+195
| +22% | +$2K | ﹤0.01% | 1857 |
|
|
2021
Q2 | $14K | Hold |
877
| – | – | ﹤0.01% | 1752 |
|
|
2021
Q1 | $14K | Hold |
877
| – | – | ﹤0.01% | 1662 |
|
|
2020
Q4 | $19K | Buy |
877
+107
| +14% | +$2.32K | ﹤0.01% | 1471 |
|
|
2020
Q3 | $11K | Buy |
770
+41
| +6% | +$586 | ﹤0.01% | 1537 |
|
|
2020
Q2 | $11K | Buy |
729
+429
| +143% | +$6.47K | ﹤0.01% | 1461 |
|
|
2020
Q1 | $4K | Hold |
300
| – | – | ﹤0.01% | 1723 |
|
|
2019
Q4 | $7K | Hold |
300
| – | – | ﹤0.01% | 1536 |
|
|
2019
Q3 | $6K | Hold |
300
| – | – | ﹤0.01% | 1268 |
|
|
2019
Q2 | $6K | Hold |
300
| – | – | ﹤0.01% | 1663 |
|
|
2019
Q1 | $7K | Hold |
300
| – | – | ﹤0.01% | 1631 |
|
|
2018
Q4 | $7K | Buy |
+300
| New | +$7K | ﹤0.01% | 1527 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 3238 |
|